Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Illinois at Chicago

About this trial

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Self-identify as disabled

Report problems with social participation

Speak English

Live in a community setting

Disqualifiers

Severe communication impairment limiting ability to verbally indicate interest in participation

Trial design

Design model

Single group

Treatments tested in this trial

  • ENGAGE

    Behavioral

    ENGAGE is a group intervention designed to improve social participation within the context of the COVID-19 pandemic.

Treatment groups

21 Participants
are divided into 1 treatment group
Group A: ENGAGEExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intervention Feasibility

Recruitment (5-7 participants per group recruited within one month), retention (80% of participants complete follow up assessments), adherence (80% of participants complete the intervention group

Time frame
8 weeks
2

Intervention Satisfaction

Client Satisfaction Questionnaire-8: 8-item scale of intervention satisfaction with a 32-point scale (higher scores indicate greater satisfaction). We will establish adequate acceptability if we achieve a mean score of 24 or greater.

Time frame
8 weeks

Secondary outcomes

1

Social Participation

PROMIS Ability to Participate in Social Roles (Cohen's d=/\> .2)

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Illinois at Chicago

Lead sponsor

National Center for Advancing Translational Sciences (NCATS)

Collaborator